Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bobby, Chawla"'
Publikováno v:
American Journal of Therapeutics. 20:e706-e709
Extensive experience in the diagnosis and treatment of tuberculosis (TB) has led to treatment guidelines, which almost always result in progressive clinical improvement and cure in the compliant patient. Failure of a patient to respond as expected ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15734dcdaa4d07a0926ba39b6871b068
https://doi.org/10.1097/mjt.0b013e3181fa0dc0
https://doi.org/10.1097/mjt.0b013e3181fa0dc0
Publikováno v:
Community Oncology. 6:300-302
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::035992740fc0353b90f992d637fe4a72
https://doi.org/10.1016/s1548-5315(11)70244-3
https://doi.org/10.1016/s1548-5315(11)70244-3
Publikováno v:
American journal of therapeutics. 19(5)
Amiodarone is used extensively in clinical practice for the treatment of arrhythmias but is associated with a number of well-known side effects. We present 3 cases of extensive thrombosis occurring secondary to intravenous amiodarone. In cases like t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d24a6cdd3eaa6734a74b58d342f2ba07
https://pubmed.ncbi.nlm.nih.gov/21150769
https://pubmed.ncbi.nlm.nih.gov/21150769
Publikováno v:
Comprehensive therapy. 35(3-4)
Erythropoietin refractory anemias represent a continuing and increasing burden on the healthcare system. The current practice of providing these patients with rHuEPO does not seem to be working. Fewer than 50% of patients respond in some studies. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64db4d3b18224dd3701ea8e78e572153
https://pubmed.ncbi.nlm.nih.gov/20043618
https://pubmed.ncbi.nlm.nih.gov/20043618
Autor:
Bobby Chawla, William Tse, Michael Craig, Aaron Cumpston, Sayed Mehdi Hamadani, Abraham S. Kanate, Salman Osman
Publikováno v:
Blood. 116:4367-4367
Abstract 4367 Introduction: Clofarabine is a purine nucleoside analogue which is approved for pediatric patients with relapsed or refractory acute lymphoblastic leukemia. A number of small phase I and II studies have shown activity in adult patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b55b4811f368d814aeaa9da08c57aa4
https://doi.org/10.1182/blood.v116.21.4367.4367
https://doi.org/10.1182/blood.v116.21.4367.4367
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.